| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |